VP, Corporate Finance
- Employer
- Intra-Cellular Therapies, Inc.
- Location
- Bedminster, NJ
- Start date
- Nov 22, 2024
View more categoriesView less categories
- Discipline
- Administration, Finance
- Required Education
- Masters Degree/MBA
- Position Type
- Full time
- Hotbed
- Pharm Country
Job Details
401K, Dental, Life, Medical, Vision
Employment Type
Full-Time
“We deliver innovative treatments to improve the lives of individuals suffering from neuropsychiatric, neurologic and other disorders”
Intra-Cellular Therapies Inc. is a publicly traded biopharmaceutical company headquartered in Bedminster, New Jersey. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. Currently celebrating our 22nd anniversary, we have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all we do, create and deliver.
This crucial role will work directly with the CFO and Executive Leadership team to provide strategic decision support, financial planning and forecasting, and enterprise performance management and analysis. This role leads all corporate financial planning and capital management activities to best align resource management decisions to our corporate objectives and enable the continued growth of our business. Additionally, this role supports the articulation of ITCI’s vision and value to internal and external stakeholders.
Job Responsibilities
- Lead the enterprise budgeting and forecasting processes, including responsibility for the full enterprise P&L, balance sheet, and cash flow
- Lead the delivery of enterprise performance management and strategic decision support processes, including period end management reporting, business reviews and ad hoc business case development
- Serve as a Finance liaison to the Board and Sr. Leadership, which includes preparation of key presentations regarding enterprise performance and financial analysis
- Drive the build and management of financial models to forecast the company’s cash positions and optimize working capital needs
- Lead long term strategic planning and scenario analysis activities to ensure effective capital allocation and maximize enterprise value
- Oversee and manage relationships with key corporate banks and external stakeholders
- Collaborate with executive leadership, finance team, investor relations, commercial, R&D and corporate communications to support the earnings process
- Collaborate with executive leadership and investor relations to support external stakeholder management, including financial competitive intelligence
- Track and evaluate sell side analyst financial models; identify and monitor key metrics used by external analysts to assess ITCI performance and position in the market
- Drive cross-functional and complex initiatives focused on process improvement, planning and forecasting system design and implementation
- Provide enterprise financial modeling capabilities to support strategic decision making across the organization
- Cultivate deep partnership and collaboration with cross-functional leadership
- Lead and develop a high-performing finance team
Job Requirements
- Corporate FP&A
- Investor Relations Business Partnership
- Capital Management (including Treasury & Cash Management and Working Capital)
Intra-Cellular Therapies is an Equal Employment Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, protected veteran status, disability or any other legally protected status.
VP, Corporate Finance Salary Range: $300K - $340K
#ITCI
Company
Intra-Cellular Therapies Inc. is a publicly traded biopharmaceutical company headquartered in New York City. Founded on Nobel-prize winning research, we launched our first commercial product in CNS in 2020 and received approval for an expanded indication in 2021. Currently celebrating our 22nd anniversary, we have a strong pipeline with projects in preclinical development stage through Phase III. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all we do, create and deliver.
“We deliver innovative treatments to improve the lives of individuals suffering from neuropsychiatric, neurologic and other disorders”.
- Website
- http://www.intracellulartherapies.com/
- Location
-
430 E 29th St Ste 900
New York
New York
10016
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert